View Abstract on PubMed
View Abstract on PubMed
View Abstract on PubMed
View Abstract on PubMed
View Abstract on PubMed
The INFOV.A.C.™ Therapy System is designed to make V.A.C.® Therapy simple and informative.
Specific indications, contraindications, warnings, precautions and safety information exist for KCI products and therapies. Healthcare providers should review the product User Manual, Safety Information and/or Instructions for Use prior to application.
The mechanisms of action for V.A.C.® Therapy include drawing wound edges together, removing infectious materials and wound fluids, promoting perfusion, maintaining a closed, moist wound healing environment and promoting granulation tissue formation.
The integrated V.A.C.® Therapy System has a unique mechanism of action whereby the delivery of negative pressure through the V.A.C.® Therapy units using proprietary V.A.C.® GRANUFOAM™ Dressings maintains a wound environment that promotes wound healing.
Under negative pressure, V.A.C.® Therapy with proprietary V.A.C.® GRANUFOAM™ Dressings applies mechanical forces to the wound to create an environment that promotes wound healing. These forces are known as macrostrain and microstrain.1
Macrostrain is the visible stretch that occurs when negative pressure contracts the foam.
Microstrain is the microdeformation at the cellular level, which leads to cell stretch.
Canister Volume: 500 and 1,000ml
Frequency: 50Hz-60Hz
Power: 60W
Power Supply: Class I Equipment
Continuous Operation
Type B Equipment
Class II or internally powered Equipment
Ordinary Equipment
Equipment not suitable for use in the presence of a flammable anesthetic mixture with air, oxygen or nitrous oxide
Storage Temperature Range: -10°C to +50°C
Operational Temperature Range: +10°C to +30°C
Relative Humidity Range: 10% to 85% non-condensing
Barometric Pressure Range: 700hPa to 1060hPa
The INFOV.A.C.™ Therapy System is an integrated wound management system for use in acute, extended and home care settings. It is intended to create an environment that promotes wound healing by secondary or tertiary (delayed primary) intention by preparing the wound bed for closure, reducing edema, promoting granulation tissue formation and perfusion, and by removing exudate and infectious material. It is indicated for patients with chronic, acute, traumatic, subacute and dehisced wounds, partial-thickness burns, ulcers (such as diabetic, venous insufficiency or pressure), flaps and grafts. When used on closed surgical incisions, it is intended to manage the environment of surgical incisions that continue to drain following sutured or staple closure by maintaining a closed environment and removing exudates via the application of negative pressure wound therapy.
V.A.C.® Therapy has the largest body of evidence to date including over 1,000 peer reviewed articles, 45 of which are randomized controlled trials (RCTs). These studies have demonstrated positive clinical outcomes of NPWT, as well as the effectiveness of V.A.C.® Therapy in diabetic foot wounds, chronic wounds (e.g., pressure ulcers and lower extremity ulcers), and a variety of acute wounds. Some of these studies are listed below.
TITLE | STUDY TYPE | DATE | AUTHORS |
---|---|---|---|
Negative pressure therapy vs standard wound care: a meta-analysis of randomized trials |
Meta analysis of RCTs | 2011 | Suisa, et al. |
Use of vacuum assisted closure therapy in the treatment of diabetic foot wounds. |
Randomized control trial | 2010 | Dalla, et al. |
Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. |
Randomized control trial | 2005 | Armstrong, et al. |
State-of-the-art treatment of chronic leg ulcers: A randomized controlled trial comparing vacuum-assisted closure (V.A.C.) with modern wound dressings. |
Randomized control trial | 2006 | Vuerstaek, et al. |
Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial. |
Randomized control trial | 2008 | Blume, et al. |
Ordering
To order any of the products listed below, please contact your KCI representative or call your local KCI Office. Click here to view our locations.
Therapy Unit
PRODUCT |
ORDERING OPTION | ||
|
Carton of 10 | ||
|
Carton of 10 |
PRODUCT | ORDERING OPTION | ||
|
Case of 5 | ||
|
Case of 5 | ||
|
Case of 5 Case of 10 |
||
|
Case of 5 | ||
|
Case of 5 | ||
|
Case of 5 Case of 10 |
||
|
Case of 5 Case of 10 |
||
|
Case of 5 Case of 10 |
||
|
Case of 5 Case of 10 |
||
|
Case of 5 Case of 10 |
||
|
Case of 5 |
||
|
Case of 5 Case of 10 |
||
|
Case of 10 |
||
|
Case of 10 |
||
|
Case of 5 Case of 10 |
||
|
Case of 5 Case of 10 |
PRODUCT | ORDERING OPTION | ||
|
Case of 5 |
PRODUCT | ORDERING OPTION | ||
|
Case of 5 Case Of 10 |
||
|
Case of 5 |
||
|
Case Of 10 |
||
|
Case of 10 | ||
|
Case Of 5 Case of 10 |
||
|
Case Of 5 Case of 10 |
PRODUCT | ORDERING OPTION | ||
|
Case of 5 | ||
|
Case of 5 | ||
|
Case of 5 |